Pyae Hein

Pyae Hein is an accomplished professional with extensive experience in antibody discovery and protein engineering. Currently serving as Associate Director at Dragonfly Therapeutics, Inc. since January 2019, Pyae Hein has also held positions as Principal Scientist and Group Head, and Staff Scientist, leading teams in these domains. Prior roles include Scientist II at Takeda, focusing on antibody and biologics discovery and engineering, as well as Scientist at Juno Therapeutics, where responsibilities centered on biophysical characterizations of scFvs for CAR-T candidates. Pyae Hein completed postdoctoral studies at the Massachusetts Institute of Technology and holds a PhD in Biochemistry from the University of Wisconsin-Madison, alongside degrees in Chemistry and Biochemistry from Virginia Tech.